This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.
This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people: a randomized, double-blind, placebo-controlled, and parallel clinical investigation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
25
Antrodia cinnamomea mycelia capsule, two capsules/day (600 mg/day) for 3 months
Placebo capsule, two capsules/day (600 mg/day) for 3 months
WanFang Hospital
Taipei, Taiwan
Immune analysis
Changes in T cell markers of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Immune analysis
Changes in B cell markers of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Antibody analysis
Changes in IgA levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Antibody analysis
Changes in IgD levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Antibody analysis
Changes in IgG levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Antibody analysis
Changes in IgE levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Antibody analysis
Changes in IgM levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Cytokine analysis
Changes in IL-1beta levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Cytokine analysis
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Changes in IL-4 levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Cytokine analysis
Changes in IL-6 levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Cytokine analysis
Changes inFN-gamma levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks
Cytokine analysis
Changes in TNF-alpha levels of 29 participants will be analyzed between baseline and week 4.
Time frame: Baseline up to 4 weeks